A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Advanced Esophageal Squamous Cell Carcinoma; Metastatic Esophageal Squamous Cell Carcinoma Interventions: Drug: Tislelizumab; Drug: Oxaliplatin; Drug: Leucovorin; Drug: 5-fluorouracil (5-FU) Sponsors: BeOne Medicines Not yet recruiting Conditions:...

LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Peripheral Arterial Disease Interventions: Device: LineMatrix® Biological Vascular Graft Sponsors: Shanghai Zhongshan Hospital Not yet recruiting Conditions: Peripheral Arterial Disease Interventions: Device: LineMatrix® Biological Vascular Graft...

A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Dyspnea; Lung Cancer (Diagnosis) Interventions: Behavioral: INSPIRE Sponsors: Massachusetts General Hospital; American Cancer Society, Inc. Not yet recruiting Conditions: Dyspnea; Lung Cancer (Diagnosis) Interventions: Behavioral: INSPIRE Sponsors:...

Description of Pain in Pediatric Patients With Cleft Lip and Palate Undergoing Alveolar Grafting Using Two Surgical Strategies: Stem Cells and Autogenous Iliac Crest Bone (Pain Evaluation in Children Undergoing Alveolar Grafting: Stem Cells vs. Iliac Crest Bone)

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Clift Lip; Cleft Palate; Alveolar Bone Loss; Postoperative Pain Interventions: Procedure: Autogenous Iliac Crest Bone Grafting; Procedure: Bioengineered Alveolar Grafting (SHED + Scaffold) Sponsors: Hospital Sirio-Libanes Completed Conditions: Clift Lip;...

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

by palligoelme@gmail.com | Jul 29, 2026 | Clinical Trials

​ Conditions: Familial Chylomicronemia Syndrome Interventions: Drug: Olezarsen Sponsors: Ionis Pharmaceuticals, Inc. Recruiting Conditions: Familial Chylomicronemia Syndrome Interventions: Drug: Olezarsen Sponsors: Ionis Pharmaceuticals, Inc....